St. Luke's Mid-America Heart Institute — Kansas City, Missouri

St. Luke's Mid-America Heart Institute is a clinical research site located in Kansas City, Missouri, United States 64111.

Crixeo Clinical Trials Trust Score: 16/100 (FAILING). This profile has not yet been claimed by the site owner.

St. Luke's Mid-America Heart Institute has participated in 8 clinical trials with 2 currently active.

Therapeutic areas: Coronary Artery Disease, Central Sleep Apnea, Obstructive Hypertrophic Cardiomyopathy.

Sponsors: Bracco Diagnostics, Inc, Respicardia, Inc., Bristol-Myers Squibb.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Kansas City

Browse all research sites in Missouri · View every site in Kansas City

Sponsor Feasibility Report

Trust Score: 16/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for St. Luke's Mid-America Heart Institute?

St. Luke's Mid-America Heart Institute has a Crixeo Trust Score of 16/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has St. Luke's Mid-America Heart Institute conducted?

St. Luke's Mid-America Heart Institute has 8 clinical trials on record, with 2 currently active. Their work covers Coronary Artery Disease, Central Sleep Apnea, Obstructive Hypertrophic Cardiomyopathy.

Is St. Luke's Mid-America Heart Institute accredited by Crixeo Clinical Trials?

St. Luke's Mid-America Heart Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about St. Luke's Mid-America Heart Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.